Title: Physician Suicide

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. 1. 1.      Review the epidemiology of Physician Suicide.

      2.         Review the rates of physician suicide in comparison to general population.

      3.         Review factors that are specific to increase the risk of physician suicide.

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Sidney Zisook MD - Professor, Department of Psychiatry, University of California San Diego.

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 12/19/2024,  Expires 12/19/2027

The direct link to the course is provided below:

This episode was made in partnership with the AAP SOHM Newborn Hospitalist Subcommittee

Title: Ankyloglossia and Breastfeeding- New Clinical Report Review

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. 1. Review the new clinical report on identification and management of ankyloglossia and its effect on breastfeeding in infants.  

   1. Review the diagnosis of ankyloglossia.  

   1. Review breastfeeding physiology.  

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Jennifer Thomas MD, MPH -  Advocate Children's Health, Milwaukee Wisconsin. American Academy of Pediatrics  Section on breastfeeding

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 8/23/2024,  Expires 8/23/2027

The direct link to the course is provided below:

Pediatric Hospital Medicine: Akyloglossia and Breastfeeding-course number EM_143697 - Pediatric Hospital Medicine: Ankyloglossia and Breastfeeding - PHM Podcast series

This is part of our annual series at the Pediatric Hospital Medicine National Conference where we ask some of the conference attendees to join us to discuss which sessions of the conference they went to and learned. Today we are lucky enough to be joined by Drs. Victoria LeBlanc, Chrissy Hrach, Nancy Chen, Lana Ismail, Maha Kaissi, Tamara Gayle & Patricia Tran. This episode is not associated with CME, we apologize for any inconvienence associated with that. 

Title: Pediatric Gastroparesis - Why so slow?

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1.  1.        Define Gastroparesis and discuss incidence and prevalence.

   2.     Discuss the differences between pediatric and adult Gastroparesis etiology and management.

   3.     Discuss the diagnosis and treatment of Gastroparesis.

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Vibha Sood MD—  Associate Professor of Pediatrics, Division of Gastroenterology and Nutrition, UPMC Children's Hospital of Pittsburgh. Director - Motility Center.

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 6/3/2024,  Expires 6/3/2027

The direct link to the course is provided below:

Pediatric Hospital Medicine: Pediatric Gastroparessis - Why So Slow?- PHM Podcast series

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=25133&dev=true

Title: What is Paroxysmal Sympathetic Hyperactivity? 

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. 1.    Review the name changes that have occurred for Paroxysmal Sympathetic Hyperactivity (PSH).

   2.       Review the current definition and symptomatology of PSH.

   3.       Review treatment and management of PSH.

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Scott H. Maurer, MD, FAAHPM—  Associate Professor of Pediatrics, Chief Division of Palliative Medicine and Supportive Care, UPMC Children's Hospital of Pittsburgh 

Hitoshi Koshiya MD - Post Graduate Year Five Child Neurology Fellow, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.). 

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 5/23/2024,  Expires 5/24/2027

The direct link to the course is provided below:

Pediatric Hospital Medicine: Paroxysmal Sympathetic Hyperactivity - PHM Podcast series

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=25153&dev=true

Title: Updates in Urinary Tract Infection

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1.               Review updates in Urinary tract infection (UTI) research.

   2.       Review Neutrophil gelatinase-associated lipocalin (NGAL) & what the research says about it's connection with UTIs.

   3.       Review the urobiome and how it's being used in UTI research. 

   4.       Review the UTI calculator and its clinical usage. 

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Associate Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Catherine Forster, MD —  Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 4/23/2024,  Expires 4/24/2027

The direct link to the course is provided below:

Pediatric Hospital Medicine: Updates in Urinary Tract Infections - PHM Podcast series

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=25056&dev=true

Please join us as Drs. Eleanor Sharp and Benjamin Miller "take over" PHM from Pittsburgh for our holiday edition. They interview the long-time host and their partner, Dr. Tony Tarchichi. There is no CME associated with this episode. Happy Holidays & Happy New Year to everyone!

Title: Opioid Use Disorders in Pediatrics

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1.               Review definition and epidemiology of Opioid Use Disorders (OUD).

   2.       Review mechanism of action of Opioids.

   3.       Review medications for treatment of Opioid Use Disorders (OUD) and harm reduction principles.

   4.       Review considerations for when and adolescent is admitted to the hospital who happens to have OUD.

Faculty: 

Planning Committee:

Allison Williams MD, — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Maggie Shang, MD —  Clinical Instructor, Department of Internal Medicine at the University of Pittsburgh School of Medicine. 

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 12/1/2023,  Expires 12/1/2026

The direct link to the course is provided below:

Pediatric Hospital Medicine: Opioid Use Disorders in Pediatrics - PHM Podcast series

https://cme.hs.pitt.edu/ISER/app/learner/loadModule?moduleId=24793&dev=true

Title: New RSV Monoclonal Antibody and Vaccine Conversation

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. Review how monoclonal antibodies work in fightin disease. 
2. Review Nirsevimab and the ACIP and AAP reccomendations for its use. 
3. Discuss how monoclonal antibodies are different from vaccines and discuss the new RSV vaccines being released. 

Faculty: 

Planning Committee:

Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Division of Pediatric Hospital Medicine

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

John Williams, MD —  Professor in the Dept. of Pediatrics at the University of Pittsburgh, Division Director for Pediatric Infectious Disease Division at University of Pittsburgh Medical Center (UPMC).

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 8/29/2023,  Expires 8/29/2026

The direct link to the course is provided below:

COMING SOON!!

This is part of our annual series at the Pediatric Hospital Medicine National Conference where we ask some of the conference attendees to join us to discuss which sessions of the conference they went to and learned. Today we are lucky enough to be joined by Drs. Kishore Vellody, Kathryn Connor, Lingie Chiu, Anna Ogena and Martiza Harper. This episode is not associated with CME, we apologize for any inconvienence associated with that. 

Title: Breastfeeding Part 2

Target Audience

This activity is directed to physicians who take care of hospitalized children, medical students, nurse practitioners, and physician assistants working in the emergency room, intensive care unit, or hospital wards.

Objectives:

Upon completion of this activity, participants should be able to:

1. Review the physiology of breastfeeding, expected weight gain in an exclusively breastfed infant and how breastmilk changes as an infant ages.
2. Review breastfeeding in an infant with bronchiolitis who may be tachypneic and the risk of aspiration.
3. Review changes in breastfeeding recommendations from the AAP and WHO.

Faculty: 

Planning Committee:

Maha Kaissi, MD, MHPE — Assistant Professor of Pediatrics, Division of Pediatric Hospital Medicine, UPMC Children's Hospital of Pittsburgh

Course Directors:

Tony R. Tarchichi MD — Assistant Professor, Department of Pediatrics, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center (UPMC.) Paul C. Gaffney Diagnostic Referral Group

Dr. Tarchichi has disclosed he was a member of the Advisory Board for meningococcal vaccine in immunocompromised patient for Sanofi Corp

Carly Dulabon, MD — Assistant Professor of Pediatrics at Northeast Ohio Medical University, Akron Children's Hospital

Conflict of Interest Disclosure:

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Disclaimer Statement:

The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Released 7/3/2023,  Expires 7/3/2026

The direct link to the course is provided below:

COMING SOON!!